Searched for
DR YK HAMIED
Cipla global CEO Umang Vohra to step down; Achin Gupta to take overCipla's global CEO Umang Vohra will step down in March 2026. Achin Gupta, currently global COO, will take over as the new MD and GCEO from ...- Torrent talks for $7 billion Cipla buyout trip on valuationTorrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...
- Why Torrent Pharma is ready to go ahead with the daunting Cipla dealAhmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the WestCipla has been closely associated with India's struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big...
- Blackstone sets its sights on buying out Hamieds from CiplaNon-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn ...
- Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.
- A perfect throwback birthday celebration for YK Hamied, Chairman, CiplaHamied celebrated his 81st birthday last week.
- InvaGen, Exelan acquisition will give Cipla manufacturing plant, R&D base in USCipla on Friday fulfilled a longstanding desire to expand its beachhead in the US by buying Hetero Pharma’s US business for about $550 mill...
- Cipla set to buy American business of Hetero Drugs for $550 millionPeople close to the transaction said Cipla will buy Invagen and Camber, Hetero’s wholly owned subsidiary, for about $550 million.
- Prabir Jha may become Cipla's new HR headPrabir Jha, who has recently quit Reliance Industries as its chief human resources officer, is reportedly considering an offer to join phar...
- Samina Vaziralli to take Cipla legacy forward; company aspires to reach 100 million consumersA week ago when Cipla announced the induction of Samina Vaziralli into the company’s board, it dispelled market rumours.
- Cipla teams up with Gilead Lifesciences to make Hepatitis C drug under voluntary licenceOn the face of it, there is nothing wrong with this kind of a deal. Pharma companies ink many such pacts on a regular basis.
- Novartis verdict is a victory for patients: YK Hamied, CiplaFor patenting of frivolous patents, unjustified patents, India is taking a very-very strong stand on that issue which will only help patien...
- Dr Reddy’s Laboratories founder Anji Reddy passes awayAnji Reddy, the pharmaceutical industry pioneer who helped establish India’s reputation as a supplier of inexpensive medicines to the world...
- Need a very pragmatic pro-national drug policy: Dr YK Hamied, Cipla"It is very important for the government to take the indigenous industry seriously. We are not consulted on any issue," says Dr Hameid.
- Indian cos in US to get $500 mn biz per year from new products: CiplaIn an interview with ET Now, Dr YK Hamied, CMD, Cipla, talks about the pharma sector and company's strategies. Excerpts:
- India is the pharmaceutical capital of the world today: Dr. YK Hamied, CMD, CiplaIn an exclusive interview with ET Now, pharmaceutical guru Dr. YK Hamied, CMD, Cipla analyses the broad trends in the Indian pharmaceutical...
- Cipla in talks with Centre to share cancer drug know-howPharma powerhouse Cipla has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radica...
- CEOs ready to rock with Samba BoysMost top Indian businessmen and CEOs are backing traditional favourites Brazil, closely followed by England for the Soccer WC next month, a...
Load More
